Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82


Brief topical sodium nitrite and its impact on the quality of life in patients with sickle leg ulcers.

Connor JL Jr, Sclafani JA, Kato GJ, Hsieh MM, Minniti CP.

Medicine (Baltimore). 2018 Nov;97(46):e12614. doi: 10.1097/MD.0000000000012614.


Elevated fetal haemoglobin levels are associated with decreased incidence of retinopathy in adults with sickle cell disease.

Mian UK, Tang J, Allende APM, Heo M, Bernstein N, Vattappally L, Schoenfeld D, Minniti CP.

Br J Haematol. 2018 Dec;183(5):807-811. doi: 10.1111/bjh.15617. Epub 2018 Nov 12.


Iron Chelation with Transdermal Deferoxamine Accelerates Healing of Murine Sickle Cell Ulcers.

Rodrigues M, Bonham CA, Minniti CP, Gupta K, Longaker MT, Gurtner GC.

Adv Wound Care (New Rochelle). 2018 Oct 1;7(10):323-332. doi: 10.1089/wound.2018.0789. Epub 2018 Oct 11.


Sickle related events following cardiac catheterisation: risk implication for other invasive procedures.

Di Maggio R, Conrey A, Taylor TN, Lederman RJ, Rogers T, Nichols J, Bouges S, Minniti CP, Kato GJ, Shet AS, Hsieh MM.

Br J Haematol. 2019 May;185(4):778-780. doi: 10.1111/bjh.15618. Epub 2018 Oct 23. No abstract available.


Use of a National Electronic Health Record Network to Describe Characteristics and Healing Patterns of Sickle Cell Ulcers.

Flattau A, Gordon H, Vinces G, Ennis WJ, Minniti CP.

Adv Wound Care (New Rochelle). 2018 Aug 1;7(8):276-282. doi: 10.1089/wound.2018.0788.


l-Glutamine and the Dawn of Combination Therapy for Sickle Cell Disease.

Minniti CP.

N Engl J Med. 2018 Jul 19;379(3):292-294. doi: 10.1056/NEJMe1800976. No abstract available.


Nutritional supplement profile of adults with sickle cell disease.

Crouch EM, Bonham VL, Abdallah K, Buscetta A, Vinces G, Heo M, Minniti CP.

Am J Hematol. 2018 May 4. doi: 10.1002/ajh.25129. [Epub ahead of print] No abstract available.


Comprehensive management reduces incidence and mortality of acute chest syndrome in patients with sickle cell disease.

Basishvili G, Gotesman J, Vandervoort K, Jacobs C, Vattappally L, Minniti CP.

Am J Hematol. 2018 Mar;93(3):E64-E67. doi: 10.1002/ajh.24994. Epub 2018 Jan 12. No abstract available.


The psychosocial impact of leg ulcers in patients with sickle cell disease: I don't want them to know my little secret.

Umeh NI, Ajegba B, Buscetta AJ, Abdallah KE, Minniti CP, Bonham VL.

PLoS One. 2017 Oct 18;12(10):e0186270. doi: 10.1371/journal.pone.0186270. eCollection 2017.


Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.

Sachdev V, Sidenko S, Wu MD, Minniti CP, Hannoush H, Brenneman CL, Waclawiw MA, Arai AE, Schechter AN, Kato GJ, Lindner JR.

Br J Haematol. 2017 Nov;179(4):648-656. doi: 10.1111/bjh.14918. Epub 2017 Sep 7.


Sickle Cell Anemia and Comorbid Leg Ulcer Treated With Curative Peripheral Blood Stem Cell Transplantation.

Connor JL Jr, Minniti CP, Tisdale JF, Hsieh MM.

Int J Low Extrem Wounds. 2017 Mar;16(1):56-59. doi: 10.1177/1534734616685636. Epub 2017 Jan 9.


Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease.

Janakiram M, Verma A, Wang Y, Budhathoki A, Suarez Londono J, Murakhovskaya I, Braunschweig I, Minniti CP.

Leuk Lymphoma. 2018 Jan;59(1):241-244. doi: 10.1080/10428194.2017.1324158. Epub 2017 Jun 7. No abstract available.


Lifespan care in SCD: Whom to transition, the patients or the health care system?

Minniti CP, Vichinsky E.

Am J Hematol. 2017 Jun;92(6):487-489. doi: 10.1002/ajh.24685. Epub 2017 Apr 6. No abstract available.


Prostacyclin-analog therapy in sickle cell pulmonary hypertension.

Weir NA, Saiyed R, Alam S, Conrey A, Desai HD, George MP, Keeley JH, Klings ES, Mehari A, Taylor JG 6th, Minniti CP, Kato GJ.

Haematologica. 2017 May;102(5):e163-e165. doi: 10.3324/haematol.2015.131227. Epub 2017 Jan 25. No abstract available.


Severe cardiac iron toxicity in two adults with sickle cell disease.

Oduor H, Minniti CP, Brofferio A, Gharib AM, Abd-Elmoniem KZ, Hsieh MM, Tisdale JF, Fitzhugh CD.

Transfusion. 2017 Mar;57(3):700-704. doi: 10.1111/trf.13961. Epub 2016 Dec 26.


Autologous stem cell-based therapy for sickle cell leg ulcer: a pilot study.

Meneses JV, Fortuna V, de Souza ES, Daltro GC, Meyer R, Minniti CP, Borojevic R.

Br J Haematol. 2016 Dec;175(5):949-955. doi: 10.1111/bjh.14326. Epub 2016 Sep 8.


Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report.

Zheng CY, Minniti CP, Chaitowitz MH.

Hemoglobin. 2016 Jun;40(3):220-2. doi: 10.3109/03630269.2016.1149077. Epub 2016 Mar 9.


Osteonecrosis of the Hip in Hematologic Disease: A Review of Conditions and Treatment Options.

Sorich MM, Cherian JJ, McElroy MJ, Banerjee S, Jones LC, Minniti CP, Mont MA.

J Long Term Eff Med Implants. 2015;25(4):253-68. Review.


Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease.

Nguyen KL, Tian X, Alam S, Mehari A, Leung SW, Seamon C, Allen D, Minniti CP, Sachdev V, Arai AE, Kato GJ.

Haematologica. 2016 Feb;101(2):e40-3. doi: 10.3324/haematol.2015.125229. Epub 2015 Nov 20. No abstract available.


Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia.

Fitzhugh CD, Hsieh MM, Allen D, Coles WA, Seamon C, Ring M, Zhao X, Minniti CP, Rodgers GP, Schechter AN, Tisdale JF, Taylor JG 6th.

PLoS One. 2015 Nov 17;10(11):e0141706. doi: 10.1371/journal.pone.0141706. eCollection 2015.


A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease.

Altman IA, Kleinfelder RE, Quigley JG, Ennis WJ, Minniti CP.

Int Wound J. 2016 Dec;13(6):1315-1324. doi: 10.1111/iwj.12522. Epub 2015 Nov 4. Review.


Critical Reviews: How we treat sickle cell patients with leg ulcers.

Minniti CP, Kato GJ.

Am J Hematol. 2016 Jan;91(1):22-30. doi: 10.1002/ajh.24134. Epub 2015 Aug 14. Review.


Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trial.

Minniti CP, Gorbach AM, Xu D, Hon YY, Delaney KM, Seidel M, Malik N, Peters-Lawrence M, Cantilena C, Nichols JS, Mendelsohn L, Conrey A, Grimes G, Kato GJ.

Lancet Haematol. 2014 Dec 1;1(3):e95-e103.


Gout and sickle cell disease: not all pain is sickle cell pain.

Gupta S, Yui JC, Xu D, Fitzhugh CD, Clark C, Siddiqui S, Conrey AK, Kato GJ, Minniti CP.

Br J Haematol. 2015 Dec;171(5):872-5. doi: 10.1111/bjh.13433. Epub 2015 Apr 20. No abstract available.


Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide.

Baird JH, Minniti CP, Lee JM, Tian X, Wu C, Jackson M, Alam S, Taylor JG 6th, Kato GJ.

Br J Haematol. 2015 Mar;168(5):737-46. doi: 10.1111/bjh.13203. Epub 2014 Nov 6.


Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).

Chakraborty PK, Schmitz-Abe K, Kennedy EK, Mamady H, Naas T, Durie D, Campagna DR, Lau A, Sendamarai AK, Wiseman DH, May A, Jolles S, Connor P, Powell C, Heeney MM, Giardina PJ, Klaassen RJ, Kannengiesser C, Thuret I, Thompson AA, Marques L, Hughes S, Bonney DK, Bottomley SS, Wynn RF, Laxer RM, Minniti CP, Moppett J, Bordon V, Geraghty M, Joyce PB, Markianos K, Rudner AD, Holcik M, Fleming MD.

Blood. 2014 Oct 30;124(18):2867-71. doi: 10.1182/blood-2014-08-591370. Epub 2014 Sep 5.


Sleep disturbance, depression and pain in adults with sickle cell disease.

Wallen GR, Minniti CP, Krumlauf M, Eckes E, Allen D, Oguhebe A, Seamon C, Darbari DS, Hildesheim M, Yang L, Schulden JD, Kato GJ, Taylor JG 6th.

BMC Psychiatry. 2014 Jul 21;14:207. doi: 10.1186/1471-244X-14-207.


Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.

King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR.

Am J Hematol. 2014 Oct;89(10):E188-92. doi: 10.1002/ajh.23805. Epub 2014 Aug 4.


Activated STING in a vascular and pulmonary syndrome.

Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Sanchez GAM, Tenbrock K, Wittkowski H, Jones OY, Kuehn HS, Lee CR, DiMattia MA, Cowen EW, Gonzalez B, Palmer I, DiGiovanna JJ, Biancotto A, Kim H, Tsai WL, Trier AM, Huang Y, Stone DL, Hill S, Kim HJ, St Hilaire C, Gurprasad S, Plass N, Chapelle D, Horkayne-Szakaly I, Foell D, Barysenka A, Candotti F, Holland SM, Hughes JD, Mehmet H, Issekutz AC, Raffeld M, McElwee J, Fontana JR, Minniti CP, Moir S, Kastner DL, Gadina M, Steven AC, Wingfield PT, Brooks SR, Rosenzweig SD, Fleisher TA, Deng Z, Boehm M, Paller AS, Goldbach-Mansky R.

N Engl J Med. 2014 Aug 7;371(6):507-518. doi: 10.1056/NEJMoa1312625. Epub 2014 Jul 16.


A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution.

Lu K, Cheng MC, Ge X, Berger A, Xu D, Kato GJ, Minniti CP.

Clin J Pain. 2014 Sep;30(9):825-30. doi: 10.1097/AJP.0000000000000036.


Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia.

Arteta M, Campbell A, Nouraie M, Rana S, Onyekwere OC, Ensing G, Sable C, Dham N, Darbari D, Luchtman-Jones L, Kato GJ, Gladwin MT, Castro OL, Minniti CP, Gordeuk VR.

J Pediatr Hematol Oncol. 2014 Apr;36(3):185-9. doi: 10.1097/MPH.0000000000000011.


Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels.

Scoffone HM, Krajewski M, Zorca S, Bereal-Williams C, Littel P, Seamon C, Mendelsohn L, Footman E, Abi-Jaoudeh N, Sachdev V, Machado RF, Cuttica M, Shamburek R, Cannon RO 3rd, Remaley A, Minniti CP, Kato GJ.

Am J Cardiol. 2013 Nov 1;112(9):1499-504. doi: 10.1016/j.amjcard.2013.06.035. Epub 2013 Sep 13.


Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.

Minniti CP, Delaney KM, Gorbach AM, Xu D, Lee CC, Malik N, Koroulakis A, Antalek M, Maivelett J, Peters-Lawrence M, Novelli EM, Lanzkron SM, Axelrod KC, Kato GJ.

Am J Hematol. 2014 Jan;89(1):1-6. doi: 10.1002/ajh.23571. Epub 2013 Sep 19.


Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea.

Vichinsky E, Torres M, Minniti CP, Barrette S, Habr D, Zhang Y, Files B; study CICL670A2201 investigators.

Am J Hematol. 2013 Dec;88(12):1068-73. doi: 10.1002/ajh.23569. Epub 2013 Sep 19.


Liver stiffness increases acutely during sickle cell vaso-occlusive crisis.

Koh C, Turner T, Zhao X, Minniti CP, Feld JJ, Simpson J, Demino M, Conrey AK, Jackson MJ, Seamon C, Kleiner DE, Kato GJ, Heller T.

Am J Hematol. 2013 Nov;88(11):E250-4. doi: 10.1002/ajh.23532. Epub 2013 Aug 1.


Pain in sickle cell disease #270.

Minniti CP, Lu K, Groninger H.

J Palliat Med. 2013 Jun;16(6):697-9. doi: 10.1089/jpm.2013.9505. Epub 2013 Apr 24. No abstract available.


Leg ulcers in sickle cell disease: current patterns and practices.

Delaney KM, Axelrod KC, Buscetta A, Hassell KL, Adams-Graves PE, Seamon C, Kato GJ, Minniti CP.

Hemoglobin. 2013;37(4):325-32. doi: 10.3109/03630269.2013.789968. Epub 2013 Apr 19.


Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease.

Paul R, Minniti CP, Nouraie M, Luchtman-Jones L, Campbell A, Rana S, Onyekwere O, Darbari DS, Ajayi O, Arteta M, Ensing G, Sable C, Dham N, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR.

Eur J Haematol. 2013 Jul;91(1):62-8. doi: 10.1111/ejh.12118. Epub 2013 May 3.


IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.

Dampier CD, Smith WR, Wager CG, Kim HY, Bell MC, Miller ST, Weiner DL, Minniti CP, Krishnamurti L, Ataga KI, Eckman JR, Hsu LL, McClish D, McKinlay SM, Molokie R, Osunkwo I, Smith-Whitley K, Telen MJ; Sickle Cell Disease Clinical Research Network (SCDCRN).

Clin Trials. 2013 Apr;10(2):319-31. doi: 10.1177/1740774513475850.


Hemodynamic predictors of mortality in adults with sickle cell disease.

Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G, Xu D, Seamon C, Adams-Graves P, Castro OL, Minniti CP, Sachdev V, Taylor JG 6th, Kato GJ, Machado RF.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):840-7. doi: 10.1164/rccm.201207-1222OC.


Impact of PCA strategies on pain intensity and functional assessment measures in adults with sickle cell disease during hospitalized vaso-occlusive episodes.

Dampier CD, Wager CG, Harrison R, Hsu LL, Minniti CP, Smith WR; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).

Am J Hematol. 2012 Oct;87(10):E71-4. doi: 10.1002/ajh.23302. Epub 2012 Aug 7. No abstract available.


Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial.

Peters-Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Guillaume E, Bellevue R, Krishnamurti L, Smith WR, Dampier CD, Minniti CP; Sickle Cell Disease Clinical Research Network (SCDCRN).

Contemp Clin Trials. 2012 Mar;33(2):291-7. doi: 10.1016/j.cct.2011.11.018. Epub 2011 Dec 2.


Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF.

Blood. 2012 Apr 19;119(16):3684-90. doi: 10.1182/blood-2011-05-349621. Epub 2011 Nov 17.


Pulmonary hypertension in sickle cell disease.

Castro O, Minniti CP, Nouraie M.

N Engl J Med. 2011 Oct 27;365(17):1646; author reply 1648-9. doi: 10.1056/NEJMc1109130. No abstract available.


Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.

Dampier CD, Smith WR, Kim HY, Wager CG, Bell MC, Minniti CP, Keefer J, Hsu L, Krishnamurti L, Mack AK, McClish D, McKinlay SM, Miller ST, Osunkwo I, Seaman P, Telen MJ, Weiner DL; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).

Am J Hematol. 2011 Dec;86(12):E70-3. doi: 10.1002/ajh.22176. Epub 2011 Sep 22.


Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.

Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, Sable C, Ensing G, Dham N, Campbell A, Arteta M, Gladwin MT, Castro O, Taylor JG 6th, Kato GJ, Gordeuk V.

J Pediatr. 2012 Feb;160(2):286-90. doi: 10.1016/j.jpeds.2011.07.018. Epub 2011 Sep 3.


Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.

Minniti CP, Wilson J, Mendelsohn L, Rigdon GC, Stocker JW, Remaley AT, Kato GJ.

Br J Haematol. 2011 Dec;155(5):634-6. doi: 10.1111/j.1365-2141.2011.08757.x. Epub 2011 Jun 8. No abstract available.


Laboratory and echocardiography markers in sickle cell patients with leg ulcers.

Minniti CP, Taylor JG 6th, Hildesheim M, O'Neal P, Wilson J, Castro O, Gordeuk VR, Kato GJ.

Am J Hematol. 2011 Aug;86(8):705-8. doi: 10.1002/ajh.22065. Epub 2011 May 31. No abstract available.


Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW; BABY HUG investigators.

Lancet. 2011 May 14;377(9778):1663-72. doi: 10.1016/S0140-6736(11)60355-3.


Predictors of osteoclast activity in patients with sickle cell disease.

Nouraie M, Cheng K, Niu X, Moore-King E, Fadojutimi-Akinsi MF, Minniti CP, Sable C, Rana S, Dham N, Campbell A, Ensing G, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR.

Haematologica. 2011 Aug;96(8):1092-8. doi: 10.3324/haematol.2011.042499. Epub 2011 May 5.

Supplemental Content

Loading ...
Support Center